LAURA POGGIALI: Open Payments
NPI 1992014195 · HAPPY VALLEY, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$958 in 55 payments from 10 companies in 2025. Trend: 2023 $246 · 2024 $835 · 2025 $958
Food & beverage: $948Education: $10
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $251 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $198 |
| ABBVIE INC. | 13 | $154 |
| Phathom Pharmaceuticals, Inc. | 1 | $110 |
| Madrigal Pharmaceuticals | 3 | $88 |
| Ardelyx, Inc. | 5 | $85 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| Aimmune Therapeutics, Inc. | 1 | $21 |
| Celltrion USA Inc. | 1 | $17 |
| Janssen Pharmaceuticals, Inc | 1 | $10 |
Products named: TREMFYA, ENTYVIO, RINVOQ, VOQUEZNA, REZDIFFRA, IBSRELA, SKYRIZI, DUPIXENT.
Industry payments across OR — which companies pay providers there.
